Compass Pathways PLC

CMPS

Company Profile

  • Business description

    Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

  • Contact

    33 Broadwick Street
    LondonW1F 0DQ
    GBR

    T: +1 716 676-6461

    E: [email protected]

    https://www.compasspathways.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Care Facilities

    Fiscal Year End

    31 December 2025

    Employees

    186

Stocks News & Analysis

video

Do you qualify as 'rich'?

Morningstar's Sim Mody speaks with Mark LaMonica about the varying definitions of rich. 
stocks

Solid sales from ASX healthcare leader

Solid device sales with shares moderately undervalued.
stocks

Megatrend Investing: ASX players to capitalise on the clean energy transition

Find out how you can benefit from global megatrends.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,683.4050.000.58%
CAC 407,875.7130.69-0.39%
DAX 4021,413.8691.84-0.43%
Dow JONES (US)44,556.04134.130.30%
FTSE 1008,566.554.22-0.05%
HKSE20,597.09192.87-0.93%
NASDAQ19,654.02262.061.35%
Nikkei 22538,831.4833.110.09%
NZX 50 Index12,844.5960.45-0.47%
S&P 5006,037.8843.310.72%
S&P/ASX 2008,416.9042.900.51%
SSE Composite Index3,229.4921.11-0.65%

Market Movers